Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Jan;17(1):58-60.
doi: 10.1007/BF01584368.

Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma

Affiliations
Review

Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma

M Reiser et al. Eur J Clin Microbiol Infect Dis. 1998 Jan.

Abstract

Raynaud's phenomenon is a common vascular side effect of chemotherapy drug regimens. Chemotherapy-induced Raynaud's phenomenon leading to acral gangrene has rarely been reported. In this report, one patient who developed gangrene after bleomycin and vincristine/vinblastine chemotherapy for AIDS-related Kaposi's sarcoma and another HIV-infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented. Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS-related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy. The literature is reviewed, and clinical symptoms, pathophysiology, and treatment options are discussed.

PubMed Disclaimer

References

    1. J Rheumatol. 1980 Sep-Oct;7(5):651-9 - PubMed
    1. Acta Med Scand. 1984;216(3):323-6 - PubMed
    1. N Engl J Med. 1991 Apr 25;324(17):1220 - PubMed
    1. Arch Dermatol. 1973 Apr;107(4):553-5 - PubMed
    1. J Clin Oncol. 1989 Jul;7(7):940-2 - PubMed

MeSH terms

LinkOut - more resources